Product Program year 2025 Source: CMS Open Payments

Trace Elements 4

Drug Total Parenteral Nutrition

NDC 0517-9310-25

Open in the dashboard

General payments

$26,169

5 payments

Research payments

$75,898

4 payments

Through program year 2025, $26,169 in general payments and $75,898 in research payments were reported against Trace Elements 4 (Total Parenteral Nutrition).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $14,085 3
2024 General $12,084 2
2024 Research $68,938 2
2021 Research $6,960 2

Breakdown

Who paid General payments · program years 2024–2025
  1. American Regent $26,169 5 payments
Top recipients General payments · program year 2025
  1. Ajay Jain Pediatric Gastroenterology · Saint Louis, MO $5,425 39% · 1 payment
  2. Thomas Ziegler Endocrinology, Diabetes & Metabolism · Atlanta, GA $4,500 32% · 1 payment
  3. Anand Reddy Nephrology · Odessa, TX $4,160 30% · 1 payment

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Pediatric Gastroenterology Pediatrics $5,425 39% · 1 practitioner
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $4,500 32% · 1 practitioner
  3. Nephrology Internal Medicine $4,160 30% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Missouri $5,425 39% · 1 recipient
  2. Georgia $4,500 32% · 1 recipient
  3. Texas $4,160 30% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

5 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record